Archive for April, 2012

Forbes Column Launches Attack on Qnexa, Contrave and lorcaserin as “dangerous”

April 19th, 2012

Forbes Magazine has just published an article from Melanie Haiken on the 5 deadliest diet drugs. Included in her list were “Qnexa and Successors” (which doesn’t even make sense.) I jotted off a quick comment and encourage readers to do so as well. http://www.forbes.com/sites/melaniehaiken/2012/04/19/5-deadliest-diet-trends/

 

Childhood Obesity Linked to Liver Cancer in Adults

April 19th, 2012

Childhood obesity has now been linked to liver cancer in adulthood. Obesity has been linked to non-alcoholic fatty liver disease (NALDF). Data presented today at the International Liver Congress 2012. Danish researchers have now shown that childhood is positively linked with developing hepatocellular carcinoma…the most common form of liver cancer in adulthood. http://medicalxpress.com/news/2012-04-childhood-obesity-linked-hepatocellular-carcinoma.html

 

Obesity Costs Exceeding Smoking

April 19th, 2012

Researchers at the Mayo Clinic have found significantly higher costs associated with obesity, especially morbid obesity, than smoking. Smokers had average health costs $1,275 higher than non-smokers but the added costs for persons with morbid obesity were $5,500 per year. http://insurancenewsnet.com/article.aspx?id=338975&type=newswires

Full study appears at:  http://www.ncbi.nlm.nih.gov/pubmed/22361992

 

Woops!

April 18th, 2012

Guess what state is seeing their health insurance premiums drop…for the second year in a row? Here’s a clue, the state’s former governor, who passed a sweeping health reform legislation, is the likely Republican candidate for President of the United States. Give Up? Read on http://www.forbes.com/sites/rickungar/2012/04/13/guess-what-state-will-see-lower-health-insurance-premiums-this-year/

 

Sign Up for Future FDA Hearings

April 17th, 2012

The safety and effectiveness of lorcaserin, developed by Arena Pharmaceuticals will be the subject of a meeting of the Endocrinologic and Metabolic Drug Advisory Committee on May 10, 2012. April 18, 2012 is the deadline for filing a request to present oral testimony. See http://www.fda.gov/AdvisoryCommittees/Calendar/ucm296516.htm

Medical Devices for the treatment of obesity will be the subject of two days of a meeting of the Gastroenterology and Urology Devices Panel on May 10 and 11, 2012.  The committee will discuss general issues regarding trial design for clinical studies on the safety and effectiveness of weight loss devices. The deadline for signing up for participating as a public witness is April

http://www.fda.gov/AdvisoryCommittees/Calendar/ucm297473.htm?utm_source=fdaSearch&utm_medium=website&utm_term=Gastroenterology%20advisory%20committee&utm_content=1


 

April 4th, 2012